Disclaimer: Opinions expressed below are my own and 🚫 necessarily represent those of my employer. Tweets/RTs/❤️ 🚫 unilaterally imply unconditional endorsement and/or 🏥 advice.

Thank you to all our #SCCT2024 influencers, ambassadors & everyone following along at home! Here are #thenumbers from Symplur 👀 Stay tuned for the Best Post Competition winners from @iamritu & @DavidjHur1 later this week!

Ccta starter kit created by @Heart_SCCT to support the formation of ccta at #SCCT2024

Outstanding 👏 talk by ⁦@KanaeMukai⁩ - How to make a case for Cardiac CTA Services in Community Hospital🔑Improve patient outcomes through evidence based care🔑Align with your organization priorities🔑Create your core team🔑Partner with others ⁦@Heart_SCCT⁩ #SCCT2024

A huge thank you to all of the women that make the field of #yescct what it is! #scct2024 #womeninctt

What a wonderful start to @Heart_SCCT with the Women in CT reception!

So glad to know and work with theee powerhouse women in CT 🔥 Great to see so many #heforshe men at the reception as well! See you all bright and early for opening sessions @Heart_SCCT tomorrow ☀️ #YesCCT

Economics of CCT - Brilliant 👏👏👏 presentation #SCCT2024 by ⁦@IbrahimMSaeed1⁩ on how to build your -Pro forma for CCTA Program- and why 20 CCTA studies is the magic number for Cardiologist to read 😀⁦@Heart_SCCT⁩ ⁦@KanaeMukai⁩ ⁦@renujain19⁩

Important business session at #scct2024 @Heart_SCCT @KanaeMukai @ChrisMaroules covering potential increase in #ccta to 386$ with strong support from members. See QR code in image

Missing out on #SCCT2024? Stay connected and follow our SCCT2024 Social Media Ambassadors for live updates and the latest in cardiovascular science! #YesCCT @nweber_12

Get ready for #SCCT2024 - 4 days jam-packed with cutting-edge science and top-notch speakers. Don't miss out on the latest #YesCCT tech in the exhibit hall! Learn more: https://t.co/c4X02khdwp @CardiacCTGuy @ChinnaiyanMD @JohnJeffreyCarr @lesleejshaw @anjali_chelliah

⚠️2024 Guideline for the Management of Lower Extremity Peripheral Artery Disease: A 📝 of the @ACCinTouch & @American_Heart‼️ #Guidelines #ACC #AHA #PAD

🔑 Normal-flow low-gradient severe AS is defined as aortic valve area ≤1.0 cm2 w/ low gradient + normal flow and occurs in approx 20-30% of patients w/ severe AS. Read more key points from a review comparing the US & European guidelines for NFLG AS: https://t.co/ZRmKDaxN8O

Has the time come for routine use of quantitative #LGE by #whyCMR for sudden cardiac death risk stratification in hypertrophic #cardiomyopathy? 🤔 https://t.co/smb7dLjUoA #cvHCM #JACCIMG

Let's go! Cardiac damage (CD) staging is ready for widespread implementation & inclusion in Tx guidelines. CD stage ≥2 should be a criterion to consider earlier intervention in asymptomatic severe AS https://t.co/x1V70ajjKm #JACCINT #vhdAS #TAVR @PPibarot

Elevated Lp(a) augments the risk of #cvMI during 8 years in follow-up in patients with low CT attenuation plaque: https://t.co/IsH4v4uYFv #JACC #cvCAD #Lpa #cvLipids #CardioEd

Very honored to introduce the study and the description of the first 100 patients today at #SCAI2024 -91% of patients had a change in diagnosis -76% had a change in medical therapy The entire cath lab testing protocol is available open access

How to evaluate cardiac masses by cardiovascular magnetic resonance parametric mapping? https://t.co/jIXBFdYGRk #cardioEd #CardioTwitter #MRI @S_RamirezFlores

What’s the new normal? Updated #echofirst reference ranges for strain measurements for all four chambers adjusted for age, sex, & other clinical variables. https://t.co/rwG2gQg977 #JACCIMG #cvImaging @john_nyb @CIUS_NTNU @ProCardio1

Fantastic paper by @amrabbasmd @PPibarot et al on @JournalASEcho on discordance between invasive and #EchoFirst gradients in #TAVR, which many of us have observed in practice and could not always explain. Discordance is frequent & cannot always be explained by pressure-recovery.